These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 33470844)

  • 1. Effect of antimicrobials on
    Santos Carvalhais BE; Souza E Silva C; Dos Santos KV
    Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug Resistance in Biofilm and Planktonic Cells of
    Montoya-Hinojosa EI; Villarreal-Treviño L; Bocanegra-Ibarias P; Camacho-Ortiz A; Flores-Treviño S
    Microb Drug Resist; 2024 Sep; 30(9):354-362. PubMed ID: 39029506
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M; Tan X; Wu T; Jurkovic M; Vialichka A; Meyer K; Mendes RE; Wenzler E
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748318
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C; Ni W; Cai X; Zhao J; Cui J
    PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofilm Eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-Sulfamethoxazole.
    Río-Chacón JMD; Rojas-Larios F; Bocanegra-Ibarias P; Salas-Treviño D; Espinoza-Gómez F; Camacho-Ortiz A; Flores-Treviño S
    Jpn J Infect Dis; 2024 Jul; 77(4):213-219. PubMed ID: 38296539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
    Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
    Di Bonaventura G; Spedicato I; D'Antonio D; Robuffo I; Piccolomini R
    Antimicrob Agents Chemother; 2004 Jan; 48(1):151-60. PubMed ID: 14693533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
    J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E; Pongrácz J; Iván M; Kristóf K
    Acta Microbiol Immunol Hung; 2015 Sep; 62(3):295-305. PubMed ID: 26551572
    [TBL] [Abstract]